prostate cancer
The latest news about prostate cancer: headlines, AI summaries and the full story from every source.
- Johnson & Johnson Experimental Immunotherapy Combination Reduces Prostate Cancer PSA Levels in Early Trial
- Johnson & Johnson Reports 75% Tumor Response Rate in Early-Stage Prostate Cancer Trial
- ORIC Initiates Phase 3 Trial for Prostate Cancer Drug Rinzimetostat
- Johnson & Johnson Study Shows Earlier Use of Prostate Cancer Drug Improves Outcomes
- Tempus AI Launches ArteraAI Prostate Test for Metastatic Hormone-Sensitive Prostate Cancer
- AstraZeneca Receives FDA AdCom Recommendation for Truqap in Prostate Cancer Treatment